Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
AM-Pharma logo — A clinical stage biopharmaceutical company leading in the de...

AM-Pharma

A clinical stage biopharmaceutical company leading in the development of a treatment for acute kidney injury

Founded 2002 The Netherlands The Netherlands 21 employees Series Unknown Total: $207.54M Biopharma, Biotechnology +2

General Information

Company Name AM-Pharma
Founded Year 2002
Location The Netherlands The Netherlands +1
Employees 21
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Series Unknown
Social

Get notified when AM-Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AM-Pharma

AM-Pharma is a clinical stage biopharmaceutical company based in The Netherlands, focusing on the development of a treatment for acute kidney injury. Established in 2000, the company has been making significant strides in the Biopharma, Biotechnology, Health Care, and Pharmaceutical industries. Recently, on 01 July 2021, the company secured a Venture Round investment from Euazeo, a clear indication of its promising prospects. AM-Pharma BV's core focus lies in the development of recombinant Alkaline Phosphatase for clinical use, positioning it at the forefront of innovation in the biopharmaceutical space. With its dedicated efforts and strategic partnerships, AM-Pharma is forging a path towards revolutionizing the treatment of acute kidney injury and garnering attention from potential investors and industry leaders.

Taxonomy: Biopharmaceutical, Clinical Stage, Therapeutics, Acute Kidney Injury, Inflammatory Diseases, Infectious Diseases, Recombinant Alkaline Phosphatase, Clinical Development, Ulcerative Colitis, Hospital-Acquired Infections, Biotech, Sepsis, Drug Development, Netherlands, AM-Pharma BV

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
01 Jul 2021
Venture Round •••••• 8
Investor Investor Investor Investor Investor Investor Investor Investor
31 Mar 2020
Debt Financing •••••• 1 •••• •••• 31 Mar 2020
Series F •••••• 8
Investor Investor Investor Investor Investor Investor
•••• •••• 		16 Jul 2019
Corporate Round •••••• 1 •••• •••• 11 May 2015

View All 11 Funding Rounds

AM-Pharma Alternatives & Competitors

AM-Pharma vs
ARTIS Development
ARTIS Development Spain

Improving health care through the use of AI technology

10 employees
Biotechnology
AM-Pharma vs
Avalo Therapeutics
Avalo Therapeutics United States

Innovation driven by compassion.

Post Ipo Equity
48 employees
Biotechnology, Health and Wellness
AM-Pharma vs
SCYNEXIS, Inc.
SCYNEXIS, Inc. United States

Advancing innovative solutions for severe rare diseases

Unknown
49 employees
Biotechnology

FAQ About AM-Pharma

A clinical stage biopharmaceutical company leading in the development of a treatment for acute kidney injury
AM-Pharma was founded in 2002.
AM-Pharma is headquartered in The Netherlands.
AM-Pharma operates in the following industries: Biopharma, Biotechnology, Health Care, Pharmaceutical.
AM-Pharma has approximately 21 employees.
AM-Pharma has completed 11 funding rounds, raising a total of $207.54M. The latest funding stage is Series Unknown.
Top alternatives and competitors to AM-Pharma include ARTIS Development, Avalo Therapeutics, SCYNEXIS, Inc., Beeline Medicines, Invion Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AM-Pharma and ARTIS Development are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AM-Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy